Fine-tuning the yeast GAL10 promoter and growth conditions for efficient recombinant membrane protein production and purification. [PDF]
Moussa R+7 more
europepmc +1 more source
Syndeins: the spectrin-binding protein(s) of the human erythrocyte membrane.
John Yu, Steven R. Goodman
openalex +1 more source
Antibody-induced linkages of plasma membrane proteins to intracellular actomyosin-containing filaments in cultured fibroblasts. [PDF]
John F. Ash+2 more
openalex +1 more source
Heterologous expression of membrane transporters in cultured cells is essential for functional characterization, but is sometimes limited by low activity. Our study compares the HDAC inhibitors butyrate, VPA and SAHA to enhance transport activity. We propose to replace butyrate by SAHA: it is equally effective, devoid of repulsive odor, costs less, and
Svenja Flögel+4 more
wiley +1 more source
Engineering cardiolipin binding to an artificial membrane protein reveals determinants for lipid-mediated stabilization. [PDF]
Abramsson ML+13 more
europepmc +1 more source
Establishment and biological characterization of radioresistant colorectal cancer cell lines
Under ionizing radiation exposure, radiation‐sensitive cancer cells exhibit oxidative stress and DNA damage, while radiation‐resistant cancer cells exhibit strong antioxidant properties and DNA damage repair. Radiotherapy resistance is a major cause of recurrence and metastasis in colorectal cancer (CRC).
Tian‐Yin Qu+10 more
wiley +1 more source
A small-molecule SARS-CoV-2 inhibitor targeting the membrane protein. [PDF]
Van Damme E+48 more
europepmc +1 more source
Occurrence of A Ca2+ ‐ and modulator protein‐activatable ATPase in the synaptic plasma membranes of brain [PDF]
Kenji Sobue+4 more
openalex +1 more source
The tumor microenvironment is a dynamic, multifaceted complex system of interdependent cellular, biochemical, and biophysical components. Three‐dimensional in vitro models of the tumor microenvironment enable a better understanding of these interactions and their impact on cancer progression and therapeutic resistance.
Salma T. Rafik+3 more
wiley +1 more source